Dry eye disease affects millions of people and is often treated with eye drops that must be applied repeatedly throughout the day. Researchers at the National University of Singapore have created a new light powered implant that offers a drug free alternative by using a photosynthetic reaction to produce therapeutic molecules directly inside the eye. Their invention aims to provide long lasting relief without the inconvenience of frequent medication.
The device is a tiny, flexible implant that sits beneath the eyelid. It contains a layer of engineered microalgae capable of performing photosynthesis when exposed to ambient light. During this process, the algae release oxygen and other beneficial molecules that help restore the tear film and reduce inflammation. Because the implant activates naturally in daylight, it provides continuous therapy without requiring patient intervention.
One of the key advantages of the system is its ability to maintain stable moisture levels on the eye’s surface. Traditional eye drops offer only temporary relief because they evaporate quickly. The photosynthetic implant, by contrast, supports the natural tear environment by improving oxygenation and promoting healthier tissue function. Laboratory tests showed that the device could operate safely under typical lighting conditions and produce therapeutic effects without causing irritation.
The researchers designed the implant to be soft, biocompatible, and comfortable for long term wear. It can be inserted through a minimally invasive procedure and remains in place for extended periods. Because it does not rely on stored drugs, it avoids issues related to dosage, degradation, or the need for frequent replacement. The team also demonstrated that the implant continues to function even under low light, ensuring consistent performance throughout the day.
This technology represents a new direction in ocular therapy by harnessing biological processes rather than pharmaceuticals. The NUS team envisions future versions that could treat other eye conditions by producing different therapeutic molecules. Their work highlights the potential of light driven biohybrid systems to provide sustained, noninvasive treatment for chronic diseases.
Here’s a brief video that explains more about the tech:
